Mereo BioPharma Group plc
MREO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$43,253 | -$29,466 | -$42,220 | $19,220 |
| Dep. & Amort. | $1,088 | $1,061 | $889 | $866 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7,390 | $4,924 | $4,768 | $4,457 |
| Change in WC | -$369 | -$1,593 | -$2,352 | -$2,490 |
| Other Non-Cash | $2,310 | $3,942 | -$9,906 | -$29,124 |
| Operating Cash Flow | -$32,834 | -$21,132 | -$48,821 | -$7,071 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$699 | $0 | -$13 | -$722 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$419 | $2,000 | $154 |
| Investing Cash Flow | -$699 | -$419 | $1,987 | -$568 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$3,188 | $0 | -$934 |
| Stock Issued | $47,000 | $11,605 | $0 | $105,990 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$853 | -$444 | $200 | -$254 |
| Financing Cash Flow | $46,147 | $7,973 | $200 | $104,802 |
| Forex Effect | -$233 | $2,818 | -$12,582 | -$1,572 |
| Net Chg. in Cash | $12,381 | -$10,761 | -$59,216 | $95,591 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $57,421 | $68,182 | $127,398 | $31,675 |
| End Cash | $69,802 | $57,421 | $68,182 | $127,265 |
| Free Cash Flow | -$33,533 | -$21,551 | -$48,834 | -$7,793 |